Patent Damages After Rule 702: Will Your Expert Survive Daubert? | IPWatchdog Unleashed

Recent amendments to Federal Rule of Evidence 702 did not invent the trial judge’s gatekeeping obligation, nor did they transform economic analysis. They did, however, sharpen the focus on the burden of establishing admissibility and whether an expert has reliably applied a valid methodology to the facts. Combined with the Federal Circuit’s increasingly demanding review of patent damages opinions, the practical message is unmistakable: the economic case must be engineered from the beginning, or you will surely suffer the consequences only after it is too late.

Congress Said No to Stolen Trademarks; The USPTO Said Yes

On December 31, 1959, Calixto Lopez led armed men into the Arechabala family’s rum distillery in Cárdenas, Cuba. The family had made rum there since 1878, building Havana Club into a brand whose English name reflected its success in the U.S. market. According to testimony Ramón Arechabala gave the Senate Judiciary Committee in 2004, Lopez pointed a machine gun at him and announced he was taking over as “Pepe,” the nickname of the company’s president and Ramón’s uncle. The family’s rum business now belonged to the Cuban government.

Federal Circuit Affirms PTAB, Rejects Narrow Reading of ‘Running Surface’ in Treadmill Patent Dispute

On Friday, the Federal Circuit affirmed a Patent Trial and Appeal Board (PTAB) decision invalidating claims of Woodway’s treadmill patent after rejecting the patentee’s central argument that the Board had improperly construed the claim term ‘running surface.’

Enanta v. Pfizer is Not About a Typo: It is About Possession of the Invention

Enanta Pharmaceuticals v. Pfizer has been widely characterized as a case that turns on the acceptance or rejection of an alleged typographical error in a provisional patent application. That characterization is inaccurate. The alleged typographical error is a distraction that obscures the fact that the U.S. Court of Appeals for the Federal Circuit analyzed the case under the wrong legal framework. Properly understood, Enanta is not about a typo at all; rather, the dispositive question is whether the inventors possessed the invention prior to the public disclosure of the allegedly infringing compound.

Other Barks & Bites for Friday, July 17: CJEU Says Commercial Partnership May Make Google Liable for Gambling Ads; CAFC Corrects CFC on Book of Wisdom; Tillis Indicates PERA Tweaks

This week in Other Barks & Bites: Senator Thom Tillis (R-NC) indicates that the Patent Eligibility Restoration Act’s language could be changed to address concerns about gene patents; the Seventh Circuit says that Teva plausibly alleged that Eli Lilly breached the terms of a Hatch-Waxman settlemen; and more.

Federal Circuit Partially Vacates Court of Federal Claims’ Assessment of Copyright Award

In a precedential decision authored by Judge Hughes on Thursday, the U.S. Court of Appeals for the Federal Circuit (CAFC) vacated-in-part and remanded a decision of the Court of Federal Claims that had awarded 4DD Holdings, LLC, and T4 Data Group, LLC $12,683,065.86 for the U.S. government’s infringement of their copyrighted software TETRA®. 4DD sued the Department of Defense (DOD) and the Department of Veterans Affairs (DVA) for infringement of its copyrighted software, TETRA, which served as an interoperability solution for military healthcare records stored by the two agencies in separate databases (dubbed the “Defense Medical Information Exchange (DMIX) program).

CAFC Affirms Two PTAB Obviousness Rulings in Canon Printhead Patent Disputes

The U.S. Court of Appeals for the Federal Circuit (CAFC) issued two decisions today affirming Patent Trial and Appeal Board (PTAB) final written decisions that found claims of three patents owned by Slingshot Printing LLC unpatentable as obvious. The rulings, issued in Slingshot Printing LLC v. Canon U.S.A., Inc., followed a set of inter partes review (IPR) proceedings that Canon U.S.A., Inc. and Canon Inc. brought against Slingshot’s printhead patents.

Subscribe to IPWatchdog

This is the best way to stay informed. We send a daily roundup of our latest news, press releases, and events.

Get Email Updates